Introduction: Globally, the three main pathogens causing serious infections are
Haemophilus influenzae type b, Streptococcus pneumoniae and Neisseria meningitidis …

Abstract Objectives The Centers for Disease Control and Prevention considers carbapenem-
resistant Enterobacteriaceae (CRE) an urgent public health threat; however, its economic …

Background Pneumococcal diseases cause substantial mortality, morbidity, and economic
burden. Evidence on data inputs for economic evaluations of interventions targeting …

Background: The measurement of health benefits is a key issue in health economic
evaluations. There is very scarce empirical literature exploring the differences of using …

Vaccines have significantly reduced the detrimental effects of numerous human infectious
diseases worldwide, helped to reduce drastically child mortality rates and even achieved …

Background: In recent years, new information has been acquired regarding the diagnosis,
treatment and prevention of acute otitis media (AOM). The Italian Pediatric Society, therefore …

Objective The objectives of this review were to identify vaccine economic evaluations that
include herd immunity and describe the methodological approaches used. Methods We …

Objective To evaluate the cost-effectiveness of introducing the 10-valent pneumococcal
conjugate vaccine (PCV10) versus the 13-valent PCV (PCV13) to the National Immunization …

Aim: To assess the cost-effectiveness in Canada of atezolizumab compared with docetaxel
or nivolumab for the treatment of advanced NSCLC after first-line platinum-doublet …

Background The clinical and economic burden associated with invasive and non-invasive
pneumococcal and non-typeable Haemophilus influenzae (NTHi) diseases is substantial in …